Frontiers in Cardiovascular Medicine (Apr 2022)
Socioeconomic Status and Prognosis of Patients With ST-Elevation Myocardial Infarction Managed by the Emergency-Intervention “Codi IAM” Network
- Helena Tizón-Marcos,
- Helena Tizón-Marcos,
- Helena Tizón-Marcos,
- Helena Tizón-Marcos,
- Beatriz Vaquerizo,
- Beatriz Vaquerizo,
- Beatriz Vaquerizo,
- Beatriz Vaquerizo,
- Beatriz Vaquerizo,
- Josepa Mauri Ferré,
- Josepa Mauri Ferré,
- Núria Farré,
- Núria Farré,
- Núria Farré,
- Núria Farré,
- Núria Farré,
- Rosa-Maria Lidón,
- Rosa-Maria Lidón,
- Joan Garcia-Picart,
- Ander Regueiro,
- Albert Ariza,
- Xavier Carrillo,
- Xavier Duran,
- Xavier Duran,
- Paul Poirier,
- Mercè Cladellas,
- Mercè Cladellas,
- Mercè Cladellas,
- Mercè Cladellas,
- Anna Camps-Vilaró,
- Anna Camps-Vilaró,
- Núria Ribas,
- Núria Ribas,
- Núria Ribas,
- Núria Ribas,
- Hector Cubero-Gallego,
- Hector Cubero-Gallego,
- Hector Cubero-Gallego,
- Jaume Marrugat,
- Jaume Marrugat
Affiliations
- Helena Tizón-Marcos
- Hospital del Mar, Servicio de Cardiología, Barcelona, Spain
- Helena Tizón-Marcos
- Grupo de Investigación Biomédica en Enfermedades del Corazón, Barcelona, Spain
- Helena Tizón-Marcos
- IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain
- Helena Tizón-Marcos
- Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares, Instituto de Salud Carlos III (ISCIII), Madrid, Spain
- Beatriz Vaquerizo
- Hospital del Mar, Servicio de Cardiología, Barcelona, Spain
- Beatriz Vaquerizo
- Grupo de Investigación Biomédica en Enfermedades del Corazón, Barcelona, Spain
- Beatriz Vaquerizo
- IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain
- Beatriz Vaquerizo
- Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares, Instituto de Salud Carlos III (ISCIII), Madrid, Spain
- Beatriz Vaquerizo
- Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
- Josepa Mauri Ferré
- Hospital Universitari GermansTrias I. Pujol, Servicio de Cardiología, Badalona, Spain
- Josepa Mauri Ferré
- Departament de Salut, Generalitat de Catalunya, Barcelona, Spain
- Núria Farré
- Hospital del Mar, Servicio de Cardiología, Barcelona, Spain
- Núria Farré
- Grupo de Investigación Biomédica en Enfermedades del Corazón, Barcelona, Spain
- Núria Farré
- IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain
- Núria Farré
- Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares, Instituto de Salud Carlos III (ISCIII), Madrid, Spain
- Núria Farré
- Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
- Rosa-Maria Lidón
- Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares, Instituto de Salud Carlos III (ISCIII), Madrid, Spain
- Rosa-Maria Lidón
- Hospital Universitari de la Valld'Hebron, Servicio de Cardiología, Barcelona, Spain
- Joan Garcia-Picart
- Hospital de la Santa Creu I. Sant Pau, Servicio de Cardiología, Barcelona, Spain
- Ander Regueiro
- 0Hospital Clínic i Provincial, Servicio de Cardiología, Barcelona, Spain
- Albert Ariza
- 1Hospital Universitario de Bellvitge, Servicio de Cardiología, L'Hospitalet de Llobregat, Barcelona, Spain
- Xavier Carrillo
- Hospital Universitari GermansTrias I. Pujol, Servicio de Cardiología, Badalona, Spain
- Xavier Duran
- IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain
- Xavier Duran
- 2AMIB, Assessoria Metodològica i Bioestadística, Barcelona, Spain
- Paul Poirier
- 3Insititut Universitaire de Cardiologie et Pneumologie de Québec, Québec, QC, Canada
- Mercè Cladellas
- Hospital del Mar, Servicio de Cardiología, Barcelona, Spain
- Mercè Cladellas
- Grupo de Investigación Biomédica en Enfermedades del Corazón, Barcelona, Spain
- Mercè Cladellas
- IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain
- Mercè Cladellas
- Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
- Anna Camps-Vilaró
- IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain
- Anna Camps-Vilaró
- Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares, Instituto de Salud Carlos III (ISCIII), Madrid, Spain
- Núria Ribas
- Hospital del Mar, Servicio de Cardiología, Barcelona, Spain
- Núria Ribas
- Grupo de Investigación Biomédica en Enfermedades del Corazón, Barcelona, Spain
- Núria Ribas
- IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain
- Núria Ribas
- Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
- Hector Cubero-Gallego
- Hospital del Mar, Servicio de Cardiología, Barcelona, Spain
- Hector Cubero-Gallego
- Grupo de Investigación Biomédica en Enfermedades del Corazón, Barcelona, Spain
- Hector Cubero-Gallego
- IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain
- Jaume Marrugat
- IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain
- Jaume Marrugat
- Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares, Instituto de Salud Carlos III (ISCIII), Madrid, Spain
- DOI
- https://doi.org/10.3389/fcvm.2022.847982
- Journal volume & issue
-
Vol. 9
Abstract
BackgroundDespite the spread of ST-elevation myocardial infarction (STEMI) emergency intervention networks, inequalities in healthcare access still have a negative impact on cardiovascular prognosis. The Family Income Ratio of Barcelona (FIRB) is a socioeconomic status (SES) indicator that is annually calculated. Our aim was to evaluate whether SES had an effect on mortality and complications in patients managed by the “Codi IAM” network in Barcelona.MethodsThis is a cohort study with 3,322 consecutive patients with STEMI treated in Barcelona from 2010 to 2016. Collected data include treatment delays, clinical and risk factor characteristics, and SES. The patients were assigned to three SES groups according to FIRB score. A logistic regression analysis was conducted to estimate the adjusted effect of SES on 30-day mortality, 30-day composite cardiovascular end point, and 1-year mortality.ResultsThe mean age of the patients was 65 ± 13% years, 25% were women, and 21% had diabetes mellitus. Patients with low SES were younger, more often hypertensive, diabetic, dyslipidemic (p < 0.003), had longer reperfusion delays (p < 0.03) compared to participants with higher SES. Low SES was not independently associated with 30-day mortality (OR: 0.95;9 5% CI: 0.7–1.3), 30-day cardiovascular composite end point (OR: 1.03; 95% CI: 0.84–1.26), or 1-year all-cause mortality (HR: 1.09; 95% CI: 0.76–1.56).ConclusionAlthough the low-SES patients with STEMI in Barcelona city were younger, had worse clinical profiles, and had longer revascularization delays, their 30-day and 1-year outcomes were comparable to those of the higher-SES patients.
Keywords
- ST-elevation myocardial infarction
- reperfusion
- primary percutaneous coronary intervention
- mortality
- inequalities